Who owns Eledon Pharmaceuticals, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ELDN from SEC Form 13F filings across 155 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 155 institutions disclosed 45.5M shares of Eledon Pharmaceuticals, Inc. worth $115.2M — about 39.7% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
155
13F holders
$115.2M
value, 2026 filers
39.7%
of shares outstanding (45.5M sh)
20
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of ELDN's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 6.6M | $16.8M | 0.0% | 5.8% | +29.6% |
| 2 | BVF INC/IL | 6.3M | $15.9M | 0.5% | 5.5% | 0.0% |
| 3 | Defilade Capital Management, L.P. | 3.5M | $8.9M | 1.5% | 3.1% | 0.0% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 3.4M | $8.6M | 0.0% | 3% | 0.0% |
| 5 | GOLDMAN SACHS GROUP INC | 2.6M | $6.5M | 0.0% | 2.2% | +2.0% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.0M | $5.0M | 0.0% | 1.7% | +1.2% |
| 7 | Ensign Peak Advisors, Inc | 1.8M | $4.4M | 0.0% | 1.5% | -16.4% |
| 8 | Catalio Capital Management, LP | 1.6M | $4.1M | 0.8% | 1.4% | -3.4% |
| 9 | STATE STREET CORP | 1.6M | $4.1M | 0.0% | 1.4% | -0.4% |
| 10 | SPHERA FUNDS MANAGEMENT LTD. | 1.4M | $3.5M | 0.5% | 1.2% | +16.9% |
| 11 | Zimmer Partners, LP | 1.2M | $3.0M | 0.1% | 1% | -24.8% |
| 12 | AWM Investment Company, Inc. | 1.1M | $2.8M | 0.3% | 1% | 0.0% |
| 13 | MILLENNIUM MANAGEMENT LLC | 789,861 | $2.0M | 0.0% | 0.7% | -19.4% |
| 14 | ADAR1 Capital Management, LLC | 652,812 | $1.7M | 0.1% | 0.6% | +0.8% |
| 15 | 22NW, LP | 636,364 | $1.6M | 1.1% | 0.6% | 0.0% |
| 16 | NORTHERN TRUST CORP | 630,758 | $1.6M | 0.0% | 0.5% | +2.3% |
| 17 | VANGUARD FIDUCIARY TRUST CO | 575,672 | $1.5M | 0.0% | 0.5% | +8.8% |
| 18 | Blue Owl Capital Holdings LP | 566,509 | $1.4M | 0.3% | 0.5% | 0.0% |
| 19 | RENAISSANCE TECHNOLOGIES LLC | 556,900 | $1.4M | 0.0% | 0.5% | +177.2% |
| 20 | VANGUARD PORTFOLIO MANAGEMENT LLC | 542,676 | $1.4M | 0.0% | 0.5% | +1.7% |
| 21 | UBS Group AG | 532,686 | $1.3M | 0.0% | 0.5% | -49.2% |
| 22 | CM Management, LLC | 525,000 | $1.3M | 0.9% | 0.5% | -8.7% |
| 23 | DIMENSIONAL FUND ADVISORS LP | 511,559 | $1.3M | 0.0% | 0.4% | -5.0% |
| 24 | JACOBS LEVY EQUITY MANAGEMENT, INC | 484,760 | $1.2M | 0.0% | 0.4% | +341.3% |
| 25 | BIT Capital GmbH | 427,000 | $1.1M | 0.0% | 0.4% | +60.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.